ZYNRELEF® is a non-opioid extended-release solution combining bupivacaine and meloxicam, which has demons ...
-
Heron Therapeutics partners with CrossLink for ZYNRELEF sales
Heron Therapeutics partners with CrossLink for ZYNRELEF sales
-
Exact Sciences projects 17% Q4 revenue growth
Exact Sciences projects 17% Q4 revenue growth
-
Exact Sciences projects 17% Q4 revenue growth
Exact Sciences projects 17% Q4 revenue growth
-
Philippines enacts new law that makes paying taxes easier
Philippines enacts new law that makes paying taxes easier
-
Philippines enacts new law that makes paying taxes easier
Philippines enacts new law that makes paying taxes easier
-
Rosen Law Firm probes Mobileye over potential misinformation
Rosen Law Firm probes Mobileye over potential misinformation
-
Rosen Law Firm probes Mobileye over potential misinformation
Rosen Law Firm probes Mobileye over potential misinformation
-
Nvidia stock soars on AI demand, boosts Nasdaq rebound
Nvidia stock soars on AI demand, boosts Nasdaq rebound
-
Fed's Logan: should not rule out another rate hike
Fed's Logan: should not rule out another rate hike
-
China's central bank commits to economic growth and market opening
China's central bank commits to economic growth and market opening